Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern

In patients with atypical hemolytic uremic syndrome (aHUS), complement blocking by eculizumab rapidly halts the process of thrombotic microangiopathy and it is associated with clear long-term hematologic and renal improvements. Eculizumab treatment consists of a 4-week initial phase with weekly IV a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Case Rep Nephrol
Prif Awduron: García Monteavaro, Camino, Peralta Roselló, Carmen, Quiroga, Borja, Baltar Martín, José María, Castillo Eraso, Lorena, de Álvaro Moreno, Fernando, Martínez Vea, Alberto, Visus-Fernández de Manzanos, María Teresa
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2016
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153492/
https://ncbi.nlm.nih.gov/pubmed/28025630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/7471082
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg